Impact of the Use of 2-Phospho-L Ascorbic Acid in the Production of Engineered Stromal Tissue for Regenerative Medicine
Cells · 2025
DOI: 10.3390/cells14141123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von David Brownell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Division, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3, Canada. Hauptthemen laut MEDLINE: Tissue Engineering, Ascorbic Acid, Regenerative Medicine, Stromal Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Fonds de recherche du Québec - Nature et technologies-Samuel-de-Champlain.
Abstract (Originalsprache)
Tissue engineering enables autologous reconstruction of human tissues, addressing limitations in tissue availability and immune compatibility. Several tissue engineering techniques, such as self-assembly, rely on or benefit from extracellular matrix (ECM) secretion by fibroblasts to produce biomimetic scaffolds. Models have been developed for use in humans, such as skin and corneas. Ascorbic acid (vitamin C, AA) is essential for collagen biosynthesis. However, AA is chemically unstable in culture, with a half-life of 24 h, requiring freshly prepared AA with each change of medium. This study aims to demonstrate the functional equivalence of 2-phospho-L-ascorbate (2PAA), a stable form of AA, for tissue reconstruction. Dermal, vaginal, and bladder stroma were reconstructed by self-assembly using tissue-specific protocols. The tissues were cultured in a medium supplemented with either freshly prepared or frozen AA, or with 2PAA. Biochemical analyses were performed on the tissues to evaluate cell density and tissue composition, including collagen secretion and deposition. Histology and quantitative polarized light microscopy were used to evaluate tissue architecture, and mechanical evaluation was performed both by tensiometry and atomic force microscopy (AFM) to evaluate its macroscopic and cell-scale mechanical properties. The tissues produced by the three ascorbate conditions had similar collagen deposition, architecture, and mechanical properties in each organ-specific stroma. Mechanical characterization revealed tissue-specific differences, with tensile modulus values ranging from 1–5 MPa and AFM-derived apparent stiffness in the 1–2 kPa range, reflecting the nonlinear and scale-dependent behavior of the engineered stroma. The results demonstrate the possibility of substituting AA with 2PAA for tissue engineering. This protocol could significantly reduce the costs associated with tissue production by reducing preparation time and use of materials. This is a crucial factor for any scale-up activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine Division, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3, Canada.
- Centre de Recherche en Organogénèse Expérimentale de L'Université Laval/LOEX, Université Laval, Québec, QC G1J 5B3, Canada.
- Centre de Recherche sur le Cancer, Université Laval, Québec, QC G1J 5B3, Canada.
- Oncology Division, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3, Canada.
- Department of Surgery, Université Laval, Québec, QC G1V 0A6, Canada.
- Université de Toulouse, CNRS UMR 5623, Laboratoire Softmat, 31062 Toulouse, France.
ORCID-Profile: David Brownell, Laurence Carignan, Christophe Caneparo, Stéphane Chabaud, François Berthod, Laure Gibot, François Bordeleau, Stéphane Bolduc
Förderung
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Fonds de recherche du Québec - Nature et technologies-Samuel-de-Champlain
- Fonds de recherche du Québec - Santé
- NSERC Discovery
- FRQNT Samuel de Champlain
- FRQS
Zitieren
APA
Brownell, D., Carignan, L., Alavi, R., Caneparo, C., Labroy, M., Galbraith, T., Chabaud, S., Berthod, F., Gibot, L., Bordeleau, F., & Bolduc, S. (2025). Impact of the Use of 2-Phospho-L Ascorbic Acid in the Production of Engineered Stromal Tissue for Regenerative Medicine. Cells. https://doi.org/10.3390/cells14141123
Vancouver
Brownell D, Carignan L, Alavi R, Caneparo C, Labroy M, Galbraith T, et al. Impact of the Use of 2-Phospho-L Ascorbic Acid in the Production of Engineered Stromal Tissue for Regenerative Medicine. Cells. 2025. doi:10.3390/cells14141123
BibTeX
@article{Brownell2025,
author = {Brownell, David and Carignan, Laurence and Alavi, Reza and Caneparo, Christophe and Labroy, Maxime and Galbraith, Todd and Chabaud, Stéphane and Berthod, François and Gibot, Laure and Bordeleau, François and Bolduc, Stéphane},
title = {Impact of the Use of 2-Phospho-L Ascorbic Acid in the Production of Engineered Stromal Tissue for Regenerative Medicine},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14141123}
}
EUVIMED